Nikonova 2010.

Methods	3‐arm parallel trial. Duration not stated.
Participants	41 people with CF with first isolate and chronic P aeruginosa infection. Bramitob® group − 21 participants (6−18 years) all with chronic infection. TOBI® group − 11 participants (3 to 15 years) 2 of them with first isolate and 9 with chronic infection. Colistin group − 9 participants (0 to 15 years) 6 of them with first isolate and 3 with chronic infection.
Interventions	Intervention 1: Bramitob®. Intervention 2: TOBI®. Intervention 3: colistin.
Outcomes	Eradication of P aeruginosa infection, lung function, nutritional status, number of exacerbations of chronic bronchopulmonary process.
Notes	Randomisation not clear. Only abstract published, await publication of full paper.